Major trial of statins to treat multiple sclerosis begins
The biggest ever trial for secondary progressive multiple sclerosis (SPMS) in the UK has begun under UCL research leadership.
Sep 13, 2018
0
0
The biggest ever trial for secondary progressive multiple sclerosis (SPMS) in the UK has begun under UCL research leadership.
Sep 13, 2018
0
0
A UCL researcher is leading a phase 3 trial involving more than 1,000 people with multiple sclerosis (MS) to investigate whether simvastatin could become a treatment for the condition.
May 9, 2017
0
3
While two large clinical trials recently showed that adding niacin to statin therapy failed to improve clinical outcomes despite a significant increase in HDL-C levels, little is known about exactly why the increased HDL-C ...
Mar 12, 2013
0
0
Delayed wound healing is a major complication of diabetes because the physiological changes in tissues and cells impair the wound healing process. This can result in additional disease outcomes such as diabetic foot ulcer, ...
Nov 27, 2012
0
0
The United States Food and Drug Administration (FDA) today announced new limitations to the use of high-dose simvastatin, due to the increased risk of muscle pain and weakness (myopathy) and in rare cases, kidney damage and ...
Jun 9, 2011
1
0
Despite their beneficial effects in treating heart disease, neither aspirin nor simvastatin appear to offer benefit to patients suffering from pulmonary artery hypertension (PAH), according to a National Institutes of Health ...
May 18, 2011
1
0